Nuveen Asset Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-275,753
| Closed | -$1.47M | – | 3549 |
|
2021
Q1 | $1.47M | Sell |
275,753
-137,229
| -33% | -$733K | ﹤0.01% | 2749 |
|
2020
Q4 | $2.21M | Buy |
412,982
+249,136
| +152% | +$1.33M | ﹤0.01% | 2461 |
|
2020
Q3 | $770K | Buy |
163,846
+30,409
| +23% | +$143K | ﹤0.01% | 2798 |
|
2020
Q2 | $814K | Sell |
133,437
-25,368
| -16% | -$155K | ﹤0.01% | 2705 |
|
2020
Q1 | $361K | Buy |
158,805
+49,117
| +45% | +$112K | ﹤0.01% | 2876 |
|
2019
Q4 | $503K | Sell |
109,688
-505,259
| -82% | -$2.32M | ﹤0.01% | 2906 |
|
2019
Q3 | $2.38M | Buy |
614,947
+96,187
| +19% | +$373K | ﹤0.01% | 2324 |
|
2019
Q2 | $3.13M | Buy |
+518,760
| New | +$3.13M | ﹤0.01% | 2226 |
|
2017
Q1 | – | Sell |
-16,175
| Closed | -$811K | – | 1492 |
|
2016
Q4 | $811K | Sell |
16,175
-97
| -0.6% | -$4.86K | ﹤0.01% | 1202 |
|
2016
Q3 | $854K | Buy |
16,272
+200
| +1% | +$10.5K | 0.01% | 1105 |
|
2016
Q2 | $665K | Buy |
16,072
+1,267
| +9% | +$52.4K | ﹤0.01% | 1114 |
|
2016
Q1 | $602 | Buy |
+14,805
| New | +$602 | ﹤0.01% | 1161 |
|